Announcements Trials
Browse Landscape

Phase

Phase 2 61Phase NA 8Phase 1/2 5Phase 1 4Phase 4 1Phase 3 1Phase 2/3 1

Status

Unknown 2Completed 2Recruiting 1

Sponsor Class

INDUSTRY 15OTHER 5NIH 2

Study Type

Interventional 5

Sponsor

Cancer Type

Endocrine 5NET 2Sarcoma 1Gynecologic 1Genitourinary 1Gastrointestinal 1Breast 1

Conditions

Breast Neoplasms 320Leukemia, Myeloid, Acute 266Multiple Myeloma 227Carcinoma, Non-Small-Cell Lung 224Prostatic Neoplasms 202Neoplasms 196Lymphoma 191Colorectal Neoplasms 184Melanoma 179Leukemia 170Recurrence 164Pancreatic Neoplasms 163Precursor Cell Lymphoblastic Leukemia-Lymphoma 160Lung Neoplasms 150Glioblastoma 134Neoplasm Metastasis 132Lymphoma, Non-Hodgkin 128Ovarian Neoplasms 123Leukemia, Lymphocytic, Chronic, B-Cell 120Myelodysplastic Syndromes 117Lymphoma, Large B-Cell, Diffuse 110Lymphoma, Mantle-Cell 108Carcinoma, Hepatocellular 103Lymphoma, Follicular 99Stomach Neoplasms 96Carcinoma, Renal Cell 89Hodgkin Disease 88Brain Neoplasms 88Sarcoma 84Burkitt Lymphoma 75

Interventions

tivozanib 1surufatinib 1avelumab 1atezolizumab 1Everolimus 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Phase 1/2 × OTHER × Carcinoma, Neuroendocrine × Clear all
NCT05000294 2026-06-05

Atezolizumab Plus Tivozanib in Immunologically Cold Tumor Types

University of Florida

Phase 1/2 Recruiting
29 enrolled
BreastEndocrineGastrointestinalGenitourinaryGynecologicNETSarcoma

Bile Duct Neoplasms, Breast Neoplasms, Gallbladder Neoplasms, Ovarian Neoplasms, Prostatic Neoplasms, Sarcoma, Vulvar Neoplasms, Carcinoma, Neuroendocrine, Neuroendocrine Tumors

NCT05747729 2023-02-28

A Single-arm, Open-label, Clinical Trial of Surufatinib/Serplulimab/Platinum/Etoposide in Neuroendocrine Carcinoma.

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

Phase 1/2 Unknown
60 enrolled
Endocrine

Carcinoma, Neuroendocrine

NCT02205515 2022-08-19

EBRT

Sunnybrook Health Sciences Centre

Phase 1/2 Completed
17 enrolled
Endocrine

Carcinoma, Neuroendocrine

NCT03278405 2020-03-18

NET-001

Sunnybrook Health Sciences Centre

Phase 1/2 Completed
10 enrolled
Endocrine

Carcinoma, Neuroendocrine

NCT02038738 2014-01-17

68Ga-DOTATATE PET Scan Imaging in Patients With Neuroendocrine Tumors

Ochsner Health System

Phase 1/2 Unknown
250 enrolled
EndocrineNET

Apudoma, Carcinoid Tumor, Adenoma, Islet Cell, Carcinoma, Neuroendocrine, Neuroendocrine Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡